To elucidate whether the increase of plasma-NGAL was rather caused by the chronic inflammation than by any degree of kidney damage, the (same) patients were re-analyzed after their medication was switched—for medical reasons—from conventional disease modifying drugs to an anti-TNF agent. The gene discussed is LCN2; the disease is Nephropathy.